Colgate Palmolive Co (CL) stock
Close on Oct 30, 2026Market cap $75.96BP/E 37.4Yield 2.18%
Earnings
Colgate Palmolive's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Colgate Palmolive's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 29, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 30, 2026before the open | – | – | – | – | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 31, 2026before the open | $5.36B | +4.9% | $0.86 | $0.99 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 1, 2026before the open | $5.32B | – | $0.80 | $0.97 | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 30, 2026before the open | $5.23B | – | -$0.05 | $0.95 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 31, 2025before the open | – | – | $0.91 | $0.91 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 1, 2025before the open | $5.11B | +1.0% | $0.91 | $0.92 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 25, 2025before the open | – | – | $0.85 | $0.91 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 24, 2025after the close | – | – | $0.90 | $0.91 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 26, 2024before the open | $5.06B | +4.9% | $0.89 | $0.91 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 26, 2024before the open | $5.07B | +6.2% | $0.83 | $0.86 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 26, 2024before the open | $4.95B | +6.9% | $0.87 | $0.87 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 27, 2023before the open | $4.92B | +10.3% | $0.86 | $0.86 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 28, 2023before the open | $4.82B | +7.5% | $0.60 | $0.77 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 28, 2023before the open | $4.77B | +8.4% | $0.45 | $0.73 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 27, 2023before the open | $4.63B | +5.1% | $0.01 | $0.77 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 28, 2022before the open | $4.46B | +0.9% | $0.74 | $0.74 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 29, 2022before the open | $4.48B | – | $0.72 | $0.72 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 29, 2022before the open | $4.40B | – | $0.66 | $0.74 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 28, 2022before the open | $4.40B | – | $0.18 | $0.79 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 29, 2021before the open | $4.41B | – | $0.75 | $0.81 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 30, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 30, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 29, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 30, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Jul 31, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Colgate Palmolive's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| net salesGAAP | FY2026 | +2% – +6% | +2% – +6% | Reaffirmed | Jul 31, 2026 |
| net sales | FY2026 | +2% – +6% | – | New | Jan 30, 2026 |
| organic sales growthnon-GAAP | FY2026 | +1% – +4% | +1% – +4% | Reaffirmed | Jul 31, 2026 |
Guidance history
Every forecast Colgate Palmolive put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Jul 31, 2026 | organic sales growth | FY2026 | +1% – +4% | Reaffirmed |
| Jul 31, 2026 | net sales | FY2026 | +2% – +6% | Reaffirmed |
| May 1, 2026 | organic sales growth | FY2026 | +1% – +4% | Reaffirmed |
| May 1, 2026 | net sales | FY2026 | +2% – +6% | New |
| Jan 30, 2026 | organic sales growth | FY2026 | +1% – +4% | New |
| Jan 30, 2026 | net sales | FY2026 | +2% – +6% | New |
| Oct 31, 2025 | gross profit margin | FY2025 | 60.1% | New |
| Oct 31, 2025 | gross profit margin | FY2025 | 60.1% | New |
| Oct 31, 2025 | organic sales growth | FY2025 | +1% – +2% | Lowered |
| Aug 1, 2025 | organic sales growth | FY2025 | +2% – +4% | New |
| Apr 25, 2025 | organic sales growth | FY2025 | +2% – +4% | New |
| Jan 24, 2025 | earnings per share growth | FY2024 | +10% – +11% | Raised |
| Jan 24, 2025 | net sales growth | FY2024 | +3% – +5% | Raised |
| Jan 24, 2025 | organic sales growth | FY2024 | +7% – +8% | Raised |
| Jul 26, 2024 | earnings per share growth | FY2024 | +8% – +11% | New |
| Jul 26, 2024 | net sales growth | FY2024 | +2% – +5% | New |
| Jul 26, 2024 | organic sales growth | FY2024 | +6% – +8% | Raised |
| Apr 26, 2024 | organic sales growth | FY2024 | +5% – +7% | Raised |
| Apr 26, 2024 | net sales growth | FY2024 | +2% – +5% | Raised |
| Jan 26, 2024 | organic sales growth | FY2024 | +3% – +5% | New |
| Jan 26, 2024 | net sales growth | FY2024 | +1% – +4% | New |
| Oct 27, 2023 | net sales growth | FY2023 | +6% – +8% | Raised |
| Oct 27, 2023 | organic sales growth | FY2023 | +7% – +8% | Raised |
| Jul 28, 2023 | net sales growth | FY2023 | +5% – +8% | Raised |
| Jul 28, 2023 | organic sales growth | FY2023 | +5% – +7% | Raised |
| Apr 28, 2023 | net sales growth | FY2023 | +3% – +6% | Raised |
| Apr 28, 2023 | organic sales growth | FY2023 | +4% – +6% | Raised |
| Jan 27, 2023 | net sales growth | FY2023 | +2% – +5% | New |
| Jan 27, 2023 | organic sales growth | FY2023 | +3% – +5% | New |
| Oct 28, 2022 | earnings-per-share decline | FY2022 | +7% – +8% | New |
| Oct 28, 2022 | net sales growth | FY2022 | +1% – +4% | Reaffirmed |
| Oct 28, 2022 | organic sales growth | FY2022 | +6% – +7% | Raised |
| Jul 29, 2022 | net sales growth | FY2022 | +1% – +4% | Reaffirmed |
| Jul 29, 2022 | organic sales growth | FY2022 | +5% – +7% | Raised |
| Apr 29, 2022 | net sales growth | FY2022 | +1% – +4% | Reaffirmed |
| Apr 29, 2022 | organic sales growth | FY2022 | +4% – +6% | Raised |
| Jan 28, 2022 | net sales growth | FY2022 | +1% – +4% | New |
| Jan 28, 2022 | organic sales growth | FY2022 | +3% – +5% | New |
| Oct 29, 2021 | organic sales | FY2021 | +3% – +5% | New |
| Oct 29, 2021 | net sales | FY2021 | +4% – +7% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Colgate Palmolive filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- News
- Results
- Results